Mainz Biomed Expands Commercial Footprint into Poland
Total addressable market in Poland is estimated at 21 million patients BERKELEY, Calif. and MAINZ, Germany, May 31, 2023 -- Mainz Biomed NV , a molecular genetics diagnostic company specializing... | May 31, 2023